Jens Biertumpel

Board Member at Pascal Biosciences

Mr. Biertumpel is managing director and co-founder of Mont Blanc Capital Management AG, a FINMA regulated asset management firm in Zurich, Switzerland. Over the past 8 years, he grew the asset management business from Europe into Asia and created the Lipper award-winning Mont Blanc China Opportunity Fund. He is also a director with Bight Petroleum, a privately held offshore exploration company. Previously, he was a director with Astrum Capital, a Hong Kong and Cayman-based hedge fund advisor. Prior to that, Mr. Biertumpel operated his own capital company and held positions with different TSXV listed companies. He graduated with a Bachelor of Arts from Simon Fraser University.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Pascal Biosciences

Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company’s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system.


Industries

Employees

1-10

Links